Výsledky vyhledávání - "Chui Kin Yuen"

Effects of Denosumab Treatment and Discontinuation on Bone Mineral Density and Bone Turnover Markers in Postmenopausal Women with Low Bone Mass

Autor: J. Christopher Gallagher, Luanda Grazette, Henry G. Bone, Javier San Martin, Paul D. Miller, Chui Kin Yuen, Michael A. Bolognese, David L. Kendler, Y.-C. Yang

Publikováno v: The Journal of Clinical Endocrinology & Metabolism. 96:972-980

Context Denosumab treatment for 24 months increased bone mineral density (BMD) and reduced bone turnover markers (BTM) in postmenopausal women. Objective The aim was to determine the effects of prior denosumab or placebo injections on BMD, BTM, and s

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::17575db21ae6bd7723976e19292e4a9d
https://doi.org/10.1210/jc.2010-1502

Zobrazit plný text záznamu

Effects of Denosumab on Bone Mineral Density and Bone Turnover in Postmenopausal Women

Autor: Henry G. Bone, Michael A. Bolognese, David L. Kendler, H. Wang, Javier San Martin, Chui Kin Yuen, Yu Liu

Publikováno v: The Journal of Clinical Endocrinology & Metabolism. 93:2149-2157

Denosumab is an investigational fully human monoclonal antibody against receptor activator of nuclear factor-kappaB ligand, a mediator of osteoclastogenesis and osteoclast survival.This study evaluated the ability of denosumab to increase bone minera

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2830f688400640ee57744247d3542af9
https://doi.org/10.1210/jc.2007-2814

Zobrazit plný text záznamu

Validation of a Two-Item Quantitative Questionnaire for the Triage of Women With Urinary Incontinence

Autor: Angelo E. Gousse, Susan L. Hendrix, Ilker Yalcin, David Muram, Ash K. Monga, Alfred E. Bent, Eric S. Meadows, Chui Kin Yuen, Carl G. Klutke

Publikováno v: Obstetrics & Gynecology. 106:767-773

OBJECTIVE: To evaluate the reproducibility, construct validity, and preferences for the 2-item Stress/Urge Incontinence Questionnaire. METHODS: The questionnaire asks a patient to recall the number of stress urinary incontinence and urge urinary inco

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e92494e96b632c1b8bb3bb12607ee208
https://doi.org/10.1097/01.aog.0000178168.33249.49

Zobrazit plný text záznamu

Detection of placental growth hormone variant and chorionic somatomammotropin-L RNA expression in normal and diabetic pregnancy by reverse transcriptase-polymerase chain reaction

Autor: Limei Hu, Janice G. Dodd, Peter A. Cattini, Margaret E. Bock, Aristides Lytras, Chui Kin Yuen

Publikováno v: Molecular and Cellular Endocrinology. 157:131-142

Diabetes is a common complication encountered during pregnancy. Earlier studies indicated that diabetic placentas bear morphological alterations consistent with modified placental differentiation, including alterations in the villous cellular content

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::17fd77de08d6d0f371db02ed4ed09e64
https://doi.org/10.1016/s0303-7207(99)00152-5

Zobrazit plný text záznamu

Bisphosphonate therapy for osteoporosis: Benefits, risks, and drug holiday

Autor: E. Michael Lewiecki, David L. Kendler, Paul D. Miller, Douglas C. Bauer, Chui Kin Yuen, K. Shawn Davison, David A. Hanley, Michael R. McClung, Steven T. Harris, Larry Dian

The amino-bisphosphonates are first-line therapy for the treatment of most patients with osteoporosis, with proven efficacy to reduce fracture risk at the spine, hip, and other nonvertebral skeletal sites. Further, bisphosphonates have been associate

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d22b7ca4e0d48df27a00d351511f350a
https://acuresearchbank.acu.edu.au/item/89w8v/bisphosphonate-therapy-for-osteoporosis-benefits-risks-and-drug-holiday

Zobrazit plný text záznamu

Denosumab densitometric changes assessed by quantitative computed tomography at the spine and hip in postmenopausal women with osteoporosis

Autor: Stefan Goemaere, Andrea Wang, Christopher Recknor, Maria Luisa Brandi, Chui Kin Yuen, Michael A. Bolognese, Sigtas Stonkus, Grattan Woodson, Edward Franek, Arne Hoiseth, David L. Kendler, Cesar Libanati, Jose R. Zanchetta, Michael R. McClung, Jacques P. Brown

Publikováno v: Journal of clinical densitometry : the official journal of the International Society for Clinical Densitometry. 16(2)

FREEDOM was a phase 3 trial in 7808 women aged 60–90 yr with postmenopausal osteoporosis. Subjects received placebo or 60 mg denosumab subcutaneously every 6 mo for 3 yr in addition to daily calcium and vitamin D. Denosumab significantly decreased

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f3b20beb41ce352c4655c075b64a1301
https://pubmed.ncbi.nlm.nih.gov/22572531

Zobrazit plný text záznamu

Bazedoxifene, a selective estrogen receptor modulator: effects on the endometrium, ovaries, and breast from a randomized controlled trial in osteoporotic postmenopausal women

Autor: David F. Archer, Ginger D. Constantine, José C Menegoci, Tobie de Villiers, Arkadi Chines, Chui Kin Yuen, Amy B. Levine, Wulf H. Utian, JoAnn V. Pinkerton

Publikováno v: Menopause (New York, N.Y.). 16(6)

OBJECTIVE The aim of this study was to evaluate the endometrial, ovarian, and breast safety of bazedoxifene used as a treatment for postmenopausal osteoporosis. METHODS Healthy women (aged 55-85 y) with osteoporosis were enrolled in a randomized, dou

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::37f44c414cd537c9cc4679c8726b8677
https://pubmed.ncbi.nlm.nih.gov/19779314

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání